LTC discussion is buzzing with US ETF speculation, fueled by MEI Pharma's $100M treasury purchase and record futures open interest. After testing key resistance near $130, the token is in a pullback, sparking community debate on its next move.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.